Five-Year Results Confirm Roche’S Polivy Combination Therapy As New Standard Of Care For Previously Untreated Aggressive Lymphoma
Five-Year Results Confirm Roche’S Polivy Combination Therapy As New Standard Of Care For Previously Untreated Aggressive Lymphoma . (MENAFN - GlobeNewsWire - Nasdaq)     Exploratory long-term follow-up analysis of the phase III POLARIX study indicated a positive trend in overall survival in favour of Polivy in combination with ...
América - MenaFN
Jordania
https://menafn.com/images/Menafn_SmallLogo.jpg
https://menafn.com/1108968684/Five-Year-Results-Confirm-RocheS-Polivy-Combination-Therapy-As-New-Standard-Of-Care-For-Previously-Untreated-Aggressive-Lymphoma
2024-12-08
rss
(MENAFN - GlobeNewsWire - Nasdaq)     Exploratory long-term follow-up analysis of the phase III POLARIX study indicated a positive trend in overall survival in favour of Polivy in combination with ...
Five-Year Results Confirm Roche’S Polivy Combination Therapy As New Standard Of Care For Previously Untreated Aggressive Lymphoma